Key result
Gynecological cancers linked to higher CVD mortality versus the general population, with ~4% of patients dying.
Why the study?
As survival in gynecological cancers has improved, cardiovascular health may critically determine long-term survival, prompting investigation into cardiovascular mortality rates and associated risk factors.
What are the mortality rates and risk factors associated with cardiovascular disease death in patients with gynecological cancers?
Cohort (n=399,399)
Yes
What are the mortality rates and risk factors associated with cardiovascular disease death in patients with gynecological cancers?
Patients with gynecological cancers have a significantly elevated risk of cardiovascular mortality compared to the general population, particularly those diagnosed at a younger age, highlighting the need for targeted cardiovascular risk management in cancer survivorship.
No takes yet. Share an insight, caveat, or question.
May warrant closer CVD monitoring in survivors; leaves open whether interventions improve outcomes.
Yang et al. (2024) conducted a cohort in Gynecological cancers (n=399,399). Gynecological cancers vs. General US population was evaluated on Cardiovascular disease (CVD) mortality. Gynecological cancers were associated with a significantly higher risk of cardiovascular mortality compared to the general US population, with 4.1% of patients dying from cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: